Russian government to postpone mandatory labeling requirement

19 November 2019
russia_moscow_large-1-

The Russian government may postpone the introduction of controversial practice of mandatory labeling of drugs on the domestic pharmaceutical market (which is scheduled to come into force on January 1, 2020) for at least six months, according to recent statements of some senior state officials and members of the Russian Parliament (State Duma), reports The Pharma Letter’s local correspondent.

Several days ago such a proposal was submitted to the State Duma by the deputy chairman of the Russian ruling party United Russia party Andrei Isaev and the first deputy head of the committee on information policy of State Duma Sergei Boyarsky.

According to authors of the bill, most market participants, among which are distributors, pharmacies and pharmaceutical producers, are still not ready to being the required and complex labeling of their drugs and there were no full-scale tests system of the new system.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical